1. Clinical Applications for Biomarkers of Acute and Chronic Graft-versus-Host Disease 
John E. Levine, Sophie Paczesny, Stefanie Sarantopoulos 
Biology of Blood and Marrow Transplantation 
Volume 18, Issue 1, Pages S116-S124 (January 2012)
DOI: /j.bbmt
Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1 Biomarker research steps.
Biology of Blood and Marrow Transplantation  , S116-S124DOI: ( /j.bbmt )
Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Biologically relevant BAFF and B cell markers in plasma, blood, and bone marrow. (A) Naive and transitional B cells are increased in patients without cGVHD, and these may serve as predictive markers of good post-HSCT health. (B) Low transitional and naive B cell numbers and high BAFF/B cell ratios may serve as markers of cGVHD.
Biology of Blood and Marrow Transplantation  , S116-S124DOI: ( /j.bbmt )
Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Possible randomized, double-blinded, placebo-controlled, trial design to test GVHD preemption.
Biology of Blood and Marrow Transplantation  , S116-S124DOI: ( /j.bbmt )
Copyright © 2012 American Society for Blood and Marrow Transplantation Terms and Conditions